Preliminary reports suggest conolidine could inhibit unique ion channels, lessening neuronal excitability and restricting discomfort alerts. This system is particularly relevant in neuropathic pain, in which irregular signaling causes persistent discomfort. In addition, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integra